Margriet G.A. Sattler
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Margriet G.A. Sattler has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
A.J. Teske
1 shared publication- András Zolnay
Department of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands
1 shared publication - Anna L. Petoukhova
Department of Medical Physics, Haaglanden Medical Center, Leidschendam, the Netherlands
1 shared publication Anne G.H. Niezink
Dept. Radiation Oncology, University Medical Center Groningen, University of Groningen, the Netherlands
1 shared publication- Anne P. G. Crijns
Department of Radiation Oncology, University Medical Center Groningen, Groningen, The Netherlands
1 shared publication Arjen van der Schaaf
Dept. Radiation Oncology, University Medical Center Groningen, University of Groningen, the Netherlands
1 shared publication
Latest Publications
- Open Access
- 4 July 2025
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 210, 110998
Selection of patients for proton therapy to reduce risk of second primary lung and breast cancer
- 4 July 2025
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 210, 110998
Open AccessSelection of patients for proton therapy to reduce risk of second primary lung and breast cancer
- Open Access
- 12 November 2024
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 69 (22) , 225014
Deep learning prediction of scenario doses for direct plan robustness evaluations in IMPT for head-and-neck
Objective. Intensity modulated proton therapy (IMPT) is susceptible to uncertainties in patient setup and proton range. Robust optimization is employed in IMPT treatment planning to ensure sufficient coverage of the clinical target volume (CTV) in predefined scenarios, albeit at a price of increased planning times. We investigated a deep learning (DL) strategy for dose predictions in individual error scenarios in head and neck cancer IMPT treatment planning, enabling direct evaluation of plan robustness. The model is able to differentiate between scenarios by using embeddings of the scenario index. Approach. To accommodate resolution disparities in planning CT-scans and accommodate the setup error scenarios, we introduced scenario-specific isocentric distance maps as inputs to the DL models. For 392 H&N cancer patients, high-quality 9-scenario ground truth (GT) robust plans were generated with wish-list driven fully automated multi-criteria optimization. The scenario index is converted to one-hot-vector that is used to derive the scenarios embeddings through the training of the DL model, aiding the model to predict a scenario specific dose distribution. Main results. The model achieved within 1%-point of agreement with the GT the predicted V 95 % of the voxelwise minimum dose for CTV Low and CTV High for 96% and 75% respectively of the test patients. Considering all robustness scenarios, median differences were 0.035%-point for CTV High V 95 % , 0.11%-point for CTV Low V 95 % , 0.29 GyE for parotids D mean , 0.7 GyE for submandibular glands D mean and 0.9 GyE for oral cavity D mean . Prediction of full 3D dose distributions for all scenarios took around 14 s. Significance. Predicting individual scenarios for robust proton therapy using DL dose prediction is feasible, enabling direct robustness evaluation of the predicted scenario doses.
- 12 November 2024
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 69 (22) , 225014
Open AccessDeep learning prediction of scenario doses for direct plan robustness evaluations in IMPT for head-and-neck
Objective. Intensity modulated proton therapy (IMPT) is susceptible to uncertainties in patient setup and proton range. Robust optimization is employed in IMPT treatment planning to ensure sufficient coverage of the clinical target volume (CTV) in predefined scenarios, albeit at a price of increased planning times. We investigated a deep learning (DL) strategy for dose predictions in individual error scenarios in head and neck cancer IMPT treatment planning, enabling direct evaluation of plan robustness. The model is able to differentiate between scenarios by using embeddings of the scenario index. Approach. To accommodate resolution disparities in planning CT-scans and accommodate the setup error scenarios, we introduced scenario-specific isocentric distance maps as inputs to the DL models. For 392 H&N cancer patients, high-quality 9-scenario ground truth (GT) robust plans were generated with wish-list driven fully automated multi-criteria optimization. The scenario index is converted to one-hot-vector that is used to derive the scenarios embeddings through the training of the DL model, aiding the model to predict a scenario specific dose distribution. Main results. The model achieved within 1%-point of agreement with the GT the predicted V 95 % of the voxelwise minimum dose for CTV Low and CTV High for 96% and 75% respectively of the test patients. Considering all robustness scenarios, median differences were 0.035%-point for CTV High V 95 % , 0.11%-point for CTV Low V 95 % , 0.29 GyE for parotids D mean , 0.7 GyE for submandibular glands D mean and 0.9 GyE for oral cavity D mean . Prediction of full 3D dose distributions for all scenarios took around 14 s. Significance. Predicting individual scenarios for robust proton therapy using DL dose prediction is feasible, enabling direct robustness evaluation of the predicted scenario doses.
- 1 October 2020
- Published by Elsevier in European Journal of Cancer
- Vol. 138, S6
The risk of cardiovascular disease in irradiated breast cancer patients: The role of cardiac calcifications and adjuvant treatment
- 1 October 2020
- Published by Elsevier in European Journal of Cancer
- Vol. 138, S6
The risk of cardiovascular disease in irradiated breast cancer patients: The role of cardiac calcifications and adjuvant treatment